Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia(1)

The objective of our study was to determine the mechanism of action of the short-chain ceramide analog, C6-ceramide, and the breast cancer drug, tamoxifen, which we show coactively depress viability and induce apoptosis in human acute myelogenous leukemia cells. Exposure to the C6-ceramide-tamoxifen...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Lipid Res
Päätekijät: Morad, Samy A. F., Ryan, Terence E., Neufer, P. Darrell, Zeczycki, Tonya N., Davis, Traci S., MacDougall, Matthew R., Fox, Todd E., Tan, Su-Fern, Feith, David J., Loughran, Thomas P., Kester, Mark, Claxton, David F., Barth, Brian M., Deering, Tye G., Cabot, Myles C.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The American Society for Biochemistry and Molecular Biology 2016
Aiheet:
Research Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4918852/
https://ncbi.nlm.nih.gov/pubmed/27140664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.M067389
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia